Combined Inhibition of mTORC1 and mTORC2 Signaling Pathways Is a Promising Therapeutic Option in Inhibiting Pheochromocytoma Tumor Growth: In Vitro and In Vivo Studies in Female Athymic Nude Mice

Alessio Giubellino(National Institutes of Health), Karel Pacák(National Institutes of Health)

Endocrinology

January 10, 2013

10.1210/en.2012-1854

Cited by 45

Related Papers

Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma

|PLoS ONE|2013|26

Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma Cells

|Endocrinology|2015|13

MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells

|Cancers|2023|8

Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma

|Veterinary Sciences|2023|1